Halozyme Therapeutics, Inc. (HALO) — Business segments and KPIs
Revenue by business segment and geography for Halozyme Therapeutics, Inc., with year-over-year trends.
FY 2025
| Segment | Revenue | % of total |
|---|---|---|
| Revenue by product | ||
| Royalty | 867.84M | 53.6% |
| Product | 376.44M | 23.3% |
| Collaborative Agreements | 152.33M | 9.4% |
| Bulk rHuPH20 | 133.02M | 8.2% |
| Sales-based milestone | 70.00M | 4.3% |
| Upfront Fees | 18.47M | 1.1% |
| Revenue by region | ||
| SWITZERLAND | 109.89M | 73.1% |
| UNITED STATES | 40.48M | 26.9% |